New York · Nonprofit
NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC
NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC (New York) receives grants from 2 organizations whose IRS filings report $240,623 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($240,000). 2 of them have funded it in more than one year.
- Revenue FY2024
- $12M
- Funders on record
- 2
- Grants received
- $241k
- Net assets
- $18M
What National Community Oncology Dispensing Association Inc does
Mission
The organization will create programs and material that will help educate patients and healthcare providers regarding oral oncology and supportive medications for the improvement of patient care.
As stated on its FY2024 Form 990.
Program
Educational programs for healthcare providers and pharmaceutical companies regarding oral oncology and supportive medications.
$10,253,849 spent$11,003,664 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $10,253,849.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $7.8M to $13M (+68%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 2%. Grants only. Government contracts and fees sit inside program revenue.
0% of NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC’s revenue is contributions — more earned-revenue than three-quarters of its peers (21% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Michael Reff
Executive director
As listed on its FY2024 Form 990.
Who funds it, year by year
2018 → 2023: the base broadened from 1 funder to 2 funders, grant income rose $15k → $30k.
1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 0% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC leans on a few funders — its largest provides 100% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC.
Largest funder’s share by year: 2018 100% · 2019 100% · 2020 100% · 2021 100% · 2022 99% · 2023 99% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC draws 100% of its grant income from funders outside New York, across 1 state in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $623 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC holds deeper cash reserves than three-quarters of the 3,288 human services nonprofits its size.
this organization peer median middle 50% of peers· 3,288 human services nonprofits $10M–$100M, FY2024
Organizations like NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
85% of spending goes to programs.
Governance
Public support
97%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Part of a family of 1 related entity
- Innovative Patient Support · disregarded
Screen this organization
A dated, signed PDF of the compliance screen for NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC?
- NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC (New York) receives grants from 2 organizations whose IRS filings report $240,623 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($240,000). 2 of them have funded it in more than one year.
- How many funders does NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC have?
- IRS filings report 2 organizations giving $240,623 in grants to NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC, 2 of which have funded it in more than one year.
- Who is the largest funder of NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC?
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is the largest funder on record, with $240,000 in grants. The full list of funders is on this page.
- How can an organization like NATIONAL COMMUNITY ONCOLOGY DISPENSING ASSOCIATION INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds National Community Oncology Dispensing Association →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing